To further determine whether changes in circulating LCN2 levels could serve as a biomarker of cancer cachexia, Receiver Operating Characteristic (ROC) analysis was performed by using the Biomarker Analysis feature of MetaboAnalyst [38]. The gene discussed is LCN2; the disease is cancer.